Leif Bertilsson

Develoment of pharmacogenomicsduring 40 years―CYP2D6 and CYP2C19 as examples

Leif Bertilsson, 2019 .

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants

Leif Bertilsson, M. Ingelman-Sundberg, L. Bertilsson, 2006, Clinical pharmacology and therapeutics.

CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population

Jaran Eriksen, Barry C Jones, Leif Bertilsson, 2006, Pharmacogenetics and genomics.

Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients

Inger Johansson, Leif Bertilsson, Magnus Ingelman‐Sundberg, 1999, International journal of cancer.